pharma · Non-Hodgkin Lymphoma
Cho-A Pharmaceutical. Co
Cho Pharma
Cho Pharma is a pharma organization headquartered in CN. Primary therapeutic focus areas include Non-Hodgkin Lymphoma. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity
Seoul, KR HQ
1988 Founded
16 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Seoul, KR
- Founded
- 1988
- Employees
- 16
- Programs
- 1
- Drugs
- 0
- Patents
- 0
CHO-H01
Phase 2 · small molecule · Non-Hodgkin Lymphoma
CHO-H01 for Non-Hodgkin Lymphoma is a Phase 2 program (small_molecule) at Cho Pharma with 1 ClinicalTrials.gov record(s).
Internal code NHLHAT-001
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Cho Pharma
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Non-Hodgkin Lymphoma
- Status
- active
- Trials
- 1